Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

DCPR classification provides diagnostic criteria to evaluate psychosomatic syndromes

An investigation headed by Piero Porcelli (Bari, Italy) has yielded new insights as to what affects how a patient perceives his/her illness. It is published in the current issue of Psychotherapy and Psychosomatics.

20 Oct 2009

Internet training could potentially enhance brain function and cognition in older adults: Study

You can teach an old dog new tricks, say UCLA scientists who found that middle-aged and older adults with little Internet experience were able to trigger key centers in the brain that control decision-making and complex reasoning after just one week of surfing the Web.

20 Oct 2009

Smoking bans reduce risk of of heart attack in nonsmokers and smokers

Smoking bans are effective at reducing the risk of heart attacks and heart disease associated with exposure to secondhand smoke, says a new report from the Institute of Medicine. The report also confirms there is sufficient evidence that breathing secondhand smoke boosts nonsmokers' risk for heart problems, adding that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling.

19 Oct 2009

Novel HIV drug to be studied in cell cultures and patients

A $6 million, five-year federal grant to The Children's Hospital of Philadelphia Research Institute will enable researchers to investigate a novel approach in treating HIV infection---a unique class of drugs focused on developing therapies for psychological and neurological effects in AIDS.

19 Oct 2009

New EVestG diagnostic technique aids in quick detection of mental and neurological illnesses

An innovative diagnostic technique invented by a Monash University researcher could dramatically fast-track the detection of mental and neurological illnesses.

19 Oct 2009

Negative symptoms represent an attractive target for drug development

A half-day workshop on issues in the design of clinical trials to evaluate treatments for negative symptoms of schizophrenia, chaired by Stephen Marder, MD, UCLA Department of Psychiatry and David Daniel, M.D., United BioSource Corporation was held 5 October 2009, as part of the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn Conference in San Diego, CA.

15 Oct 2009

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

A new survey of 2,001 adults living with depression revealed that despite being diagnosed for an average of 12 years, many unknowingly took actions that could have sabotaged their chances of getting well. Furthermore, on average, it took about six years for respondents to seek diagnosis from a health care professional, suggesting these adults may have been coping with depression for as long as 18 years.

15 Oct 2009

National Institutes of Health grants $12 million to WCDRC for obesity research

The Miriam Hospital's Weight Control and Diabetes Research Center (WCDRC) recently received six research grants from the National Institutes of Health - totaling more than $12 million in funding - that will support the work of researchers focused on the prevention and treatment of obesity.

15 Oct 2009

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

NYU Langone Medical Center has received a five-year, $10 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center for the Neuroscience of Mental Disorders. The center, named after the late Silvio O. Conte, a U.S. congressman and advocate for mental health research, will study the onset of schizophrenia. Schizophrenia is a disease with cognitive dysfunction, affecting approximately one percent of the population worldwide.

15 Oct 2009

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

Five research teams receive $2.4 million to help breast cancer survivors

A total of $2.4 million has been awarded to five research teams in the Canadian Breast Cancer Research Alliance/Canadian Breast Cancer Foundation Special Research Competition on Psychosocial Aspects of Breast Cancer.

15 Oct 2009

Study: Psychiatrists can distinguish competent defendants from incompetent ones

Court cases across America often feature expert testimony that offers conflicting conclusions. When this happens in cases involving psychiatric expertise, does it mean that one side or the other is necessarily being less than honest?

14 Oct 2009

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

A new neurosurgical procedure may prove helpful for patients with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was found generally safe and provided significant improvement of depressive symptoms in a small group of patients, according to lead researcher Ziad Nahas, M.D. at the Medical University of South Carolina. The data are reported in the on-line issue of Biological Psychiatry.

14 Oct 2009

Cochlear implant inventor chosen for neuroscience research

Dr. Michael Merzenich, PhD - renowned neuroscientist, university professor, cochlear implant inventor, brain plasticity expert and tech entrepreneur - was formally inducted in the Institute of Medicine (IOM) today in Washington, D.C.

13 Oct 2009

Study finds that stranger homicide by people with schizophrenia rare

International study led by Sydney researchers shows homicides of strangers by people with schizophrenia are exceptionally rare and unpredictable events

12 Oct 2009

Homicides of strangers by people with schizophrenia are exceptionally rare, says study

International study led by Sydney researchers shows homicides of strangers by people with schizophrenia are exceptionally rare and unpredictable events

12 Oct 2009

Streamwood Behavioral Hospital implements initiatives to improve patient services

Using the findings and research generated by three professional operations surveys, the leadership of Streamwood Behavioral Hospital announced today they will initiate improvements to bring its patient service programs to a "gold standard" of care.

12 Oct 2009

WCMC-Q program highlights the importance of mental health to overall physical health

Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.

12 Oct 2009

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

For the first time, sufferers of schizophrenia and bipolar disorder are being brought together in a major new study investigating the diseases' common genetic causes and manifestations.

11 Oct 2009

Biocodex secures consumer distribution with CVS stores nationwide for its Florastor

As part of its continued expansion throughout the U.S. retail market, Biocodex, Inc., the U.S. arm of the French manufacturer of Florastor® and Florastor® Kids, has secured consumer distribution with CVS stores nationwide beginning this month. Florastor will be placed on-shelf in the stomach/digestives aisle, while Florastor Kids will be available upon request “behind the counter.”

8 Oct 2009

Psychiatry News and Research

Further Reading

DCPR classification provides diagnostic criteria to evaluate psychosomatic syndromes

Internet training could potentially enhance brain function and cognition in older adults: Study

Smoking bans reduce risk of of heart attack in nonsmokers and smokers

Novel HIV drug to be studied in cell cultures and patients

New EVestG diagnostic technique aids in quick detection of mental and neurological illnesses

Negative symptoms represent an attractive target for drug development

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

National Institutes of Health grants $12 million to WCDRC for obesity research

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Five research teams receive $2.4 million to help breast cancer survivors

Study: Psychiatrists can distinguish competent defendants from incompetent ones

New neurosurgical procedure may prove helpful for patients with treatment-resistant depression

Cochlear implant inventor chosen for neuroscience research

Study finds that stranger homicide by people with schizophrenia rare

Homicides of strangers by people with schizophrenia are exceptionally rare, says study

Streamwood Behavioral Hospital implements initiatives to improve patient services

WCMC-Q program highlights the importance of mental health to overall physical health

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

Biocodex secures consumer distribution with CVS stores nationwide for its Florastor

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News